Curcumin for Type 2 Diabetes
Verdict: Published with Warning
Across 6 PubMed studies, the evidence for Curcumin in Type 2 Diabetes grades Tier B — preliminary evidence. Effective, but with safety or population caveats.
B 🟡 B Preliminary Evidence Published with Warning
Why this grade7-layer evidence engine
⚖️
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditableRaw score 0.61
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published with Warning
Confidence
82%
Highly consistent evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)
▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.611
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (4 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
PubMed studies (6)L2 · primary research & systematic reviews
Curcumin extract for prevention of type 2 diabetes
Finding: Over 9 months 16.4% of the placebo group progressed to T2DM versus 0% in the curcumin group, with better HOMA-beta (61.58 vs 48.72, P<0.01) and lower HOMA-IR (3.22 vs 4.04, P<0.001).
View on PubMed Antidiabetic and Metabolic Effects of Turmeric (Curcuma Longa) in Patients with Type 2 Diabetes Mellitus or Hyperglycemia - A Systematic Meta-Review and Meta-Analysis
Finding: Curcumin significantly reduced FBG (MD -6.30 mg/dL, 95% CI -9.33 to -3.27) and HbA1c (MD -0.31%, 95% CI -0.57 to -0.05), but had no significant effect on total cholesterol, blood pressure, BMI, or renal markers, with high heterogeneity.
View on PubMed Curcumin/Turmeric Supplementation on Glycemic Control in Adults With Prediabetes and Type 2 Diabetes: A Systematic Review and Dose-Response Meta-Analysis
Finding: Curcumin/turmeric significantly reduced FBG (WMD -10.15 mg/dL, 95% CI -12.59 to -7.72), HbA1c (WMD -0.32%, 95% CI -0.43 to -0.21) and HOMA-IR (WMD -0.46), with efficacy greater at doses >=1 g/day, but substantial heterogeneity warrants caution.
View on PubMed Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Finding: Nanocurcumin showed NO significant effect on HbA1c (SMD 0.19, 95% CI -1.26 to 1.65) or fasting glucose (SMD -0.44, 95% CI -2.16 to 1.28); only antioxidant markers improved, undercutting the idea that better bioavailability yields glycemic benefit.
View on PubMed Turmeric and curcuminoids ameliorate disorders of glycometabolism among subjects with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Finding: Turmeric/curcuminoids lowered FBG by -7.86 mg/dL (95% CI -12.04 to -3.67, P=0.0002), HbA1c by -0.38% (95% CI -0.52 to -0.23, P<0.00001) and HOMA-IR by -1.01, though with significant heterogeneity.
View on PubMed Curcumin Attenuates Hyperglycemia and Inflammation in Type 2 Diabetes Mellitus: Quantitative Analysis of Randomized Controlled Trial
Finding: Curcumin significantly reduced FBG (MD -11.48 mg/dL, 95% CI -14.26 to -8.70, P<0.01), HbA1c (MD -0.54%, 95% CI -0.73 to -0.35, P<0.01) and CRP (SMD -0.59, P=0.03); this upper-end HbA1c estimate exceeds larger pooled analyses.
View on PubMed Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …
L4b EU EFSA
Cautious
the Panel established an ADI for curcumin of 3 mg/kg bw/day source↗
L4c UK NHS
Cautious
Avoid turmeric and curcumin in individuals with bile duct obstruction, cholangitis, liver disease, gallstones, or any biliary disease. source↗
L4d TW TFDA / 衛福部
Cautious
薑黃素每人每日攝取量為每公斤體重0~3毫克，每日不超過200毫克為宜 source↗
L4e WHO
Neutral
Rhizoma Curcumae Longae source↗
L5a NIH Office of Dietary Supplements
Cautious
We don't know enough to definitively conclude if turmeric or curcumin is beneficial for any health purposes. source↗
L5b Mayo Clinic
Cautious
Although curcumin or turmeric has anti-inflammatory properties, if you are diagnosed with a condition such as cancer or diabetes, speak to your health care provider before taking the supplement. source↗
L5d Harvard Health
Cautious
people with diabetes should be aware that turmeric can lower blood sugar. source↗
L5e Specialty Society (condition-mapped)
Cautious
There is insufficient evidence to support the routine use of curcumin (e.g., turmeric) to improve glycemia in people with type 1 or type 2 diabetes. source↗